课题基金 / 基金详情

Direct 19F- and 18F- fluorination of heterocycles for medicinal chemistry and radiotracer synthesis

Direct 19F- and 18F- fluorination of heterocycles for medicinal chemistry and radiotracer synthesis
用于药物化学和放射性示踪剂合成的杂环直接 19F- 和 18F- 氟化
批准号:
520227-2017
负责人:
Britton, Robert
金额:
$11.66万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Britton, Robert的其他基金

相似基金

相关文献

中文摘要
翻译
氟是地球上第13种最丰富的元素,主要存在于地壳的矿物成分中。生命系统并不常用这种元素,但由于C-F键的强度,这种元素在有机化学中有很多用途,有机氟化合物--含有C-F键的化合物--通常用作制冷剂、电绝缘剂和烹饪用具(如聚四氟乙烯)。有机氟化合物的另一个主要作用是在药物中,将单个氟原子放置在药物上的正确位置可以对分子的生物性质产生重大和期望的影响。在所有商业化药物中,约20%含有氟,包括各种类别的重要药物。此外,一种不稳定的氟同位素F-18经常用于正电子发射断层扫描(PET)成像,这是一项允许临床医生检查活体受试者中癌细胞生长等生化过程的技术。然而,尽管氟在制药和医学中具有重要意义,但将氟原子放置在分子的特定位置仍然是困难的。SFU的布里顿小组与世界上最大的制药公司之一F.Hoffmann LaRoche合作,开发了几种方法,在温和的条件下将氟原子引入分子中。这使得新的氟化分子的产生成为可能,包括F-18标记分子,可以通过PET成像检测小鼠体内的癌症肿瘤。这一研究项目旨在扩大生物医学研究人员可用的方法,以快速、温和地将氟原子引入药物分子中,以优化其性质,或用于创建新的PET显像剂。
英文摘要
Fluorine is the 13th most abundant element on earth, and exists primarily in mineral compositions in the earths crust. It is not commonly used by living systems, but this element has found many uses in organic chemistry, due to the strength of the C-F bond, and organofluorine compounds - compounds that contain a C-F bond - are commonly used as refrigerants, electric insulants and cookware (as PTFE). Another major role for organofluorine compounds is in drugs, where placing a single fluorine atom in the correct position on a pharmaceutical can have major and desireable impact on the biological properties of the molecule. Of all commercialized drugs, approximately 20% contain fluorine, including important drugs in various classes. Furthermore, an unstable isotope of fluorine, F-18, is routinely used for positron emission tomography (PET) imaging, a technique that allows clinicians to examine biochemical processes such as cancer cell growth in a live subject. However, despite the importance of fluorine in pharmaceuticals and medicine, it is still difficult to place a fluorine atom in a specific position of a molecule. The Britton group at SFU, in collaboration with F. Hoffmann LaRoche - one of the largest pharmaceutical companies in the world - has developed several methods to introduce a fluorine atom into a molecule under gentle conditions. This has enabled the creation of novel fluorinated molecules, including F-18 labeled molecules that can detect cancerous tumors in mice via PET imaging. This research project aims to expand the methods available to biomedical researchers to quickly and gently introduce a fluorine atom into drug molecules for the purpose of optimizing their properties, or for the purposes of creating new PET imaging agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and Development of Enabling Tools for the Synthesis and Late-Stage Modification of Natural Products and Pharmaceuticals
  • 批准号:
    RGPIN-2019-06468
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $7.65万
  • 财政年份:
    2022
  • 负责人:
    Britton, Robert
  • 依托单位:
Discovery and Development of Enabling Tools for the Synthesis and Late-Stage Modification of Natural Products and Pharmaceuticals
  • 批准号:
    RGPIN-2019-06468
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $7.65万
  • 财政年份:
    2021
  • 负责人:
    Britton, Robert
  • 依托单位:
A Scalable Synthesis of the C14-C23 Fragment of Eribulin
  • 批准号:
    555427-2020
  • 项目类别:
    Alliance Grants
  • 资助金额:
    $3.5万
  • 财政年份:
    2020
  • 负责人:
    Britton, Robert
  • 依托单位:
Discovery and Development of Enabling Tools for the Synthesis and Late-Stage Modification of Natural Products and Pharmaceuticals
  • 批准号:
    RGPIN-2019-06468
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $7.65万
  • 财政年份:
    2020
  • 负责人:
    Britton, Robert
  • 依托单位:
国内基金
海外基金
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
多元素(19F/23Na/31P/129Xe)磁共振成像前沿研究
适用膜蛋白-配体复合物结构测定的1H和19F距离约束检测的固体NMR方法研究
  • 批准号:
    JCZRYB202500181
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
19F/1H双模态钆基自组装探针:肿瘤磁共振成像特异性—灵敏度协同增强机制研究
  • 批准号:
    225B2402
  • 项目类别:
    青年学生基础研究项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    徐海东
  • 依托单位: